Indi (Integrated Diagnostics) scientists have found that people with lung cancer have high levels of a certain proteins in their blood, that can distinguish between benign lung nodules and early-stage lung cancer.
Researchers found that a protein called isocitrate dehydrogenase is present at high levels in lung cancers and can be a marker for the disease.
“These studies suggest that Indi’s technology is capable of detecting the molecular signature of lung cancer by measuring the presence of multiple proteins in a patient’s blood,” said Paul Kearney, Ph.D., president and chief science officer
“We are very pleased that the data suggest we have achieved a 90 percent probability with this diagnostic classifier.”
For more information about the diagnostics of Pulmonary Nodules with a non-invasive blood test visit, Integrated Diagnostics